2011
DOI: 10.1007/s10120-011-0042-4
|View full text |Cite
|
Sign up to set email alerts
|

Japanese gastric cancer treatment guidelines 2010 (ver. 3)

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

9
948
0
3

Year Published

2015
2015
2022
2022

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 2,014 publications
(960 citation statements)
references
References 26 publications
9
948
0
3
Order By: Relevance
“…Japanese gastric cancer treatment guidelines (Ver. 3) also specifies D2 lymphadenectomy as the standard operation [6] . Focus and difficulty of D2 radical surgery subgroup among the no vascular variation population in Table 5.…”
Section: Results From Comparing Observational Indices In Each Groupmentioning
confidence: 99%
“…Japanese gastric cancer treatment guidelines (Ver. 3) also specifies D2 lymphadenectomy as the standard operation [6] . Focus and difficulty of D2 radical surgery subgroup among the no vascular variation population in Table 5.…”
Section: Results From Comparing Observational Indices In Each Groupmentioning
confidence: 99%
“…In this current study, we could successfully and safely perform laparoscopy assisted distal gastrectomy with D1 plus lymphadenectomy for distal gastric cancer guided by the oncologic surgical principles [19]. Although in this study we reused several times the single use hand piece of vascular sealing device for dissection and hemostasis; the advantages of minimal invasive surgery like précised dissection have been maintained.…”
Section: Discussionmentioning
confidence: 96%
“…Perigastric and left gastric lymphadenectomy (D1 plus) lymphadenectomy was tried in all patients according to the guidelines of the Japanese gastric cancers treatment [19].…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…It was expanded to include clinical stage T1‐2 cancers with or without perigastric lymph node metastasis, except for lesions for which endoscopic submucosal dissection (ESD) was indicated 8, 9. So far, in Korea and Japan, neither robotic nor laparoscopic gastrectomy is indicated for the treatment of serosa‐involved advanced gastric cancer 10. As there are some reports on serosa‐involved gastric cancer in the use of robotics or laparoscopy, it seems that it would not be a clear contraindication to a minimally invasive approach.…”
Section: Indications Of Robotic Applicationmentioning
confidence: 99%